STAT5 is phosphorylated in endothelial cells treated with IL-3, which suggests an involvement in angiogenesis and cell motility[67], and it is therefore also possible that IL-3 may play a role in breast cancer cells. This evidence concerns the gene STAT5A and breast carcinoma.